PRE 14C

INFORMATION STATEMENT

Company: Raphael Pharmaceutical Inc.
Filed: May 23, 2024
Period of Report: May 23, 2024
Accession Number: 0001213900-24-046277

View Document ↗ View on SEC.gov ↗